Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10528196rdf:typepubmed:Citationlld:pubmed
pubmed-article:10528196lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C1337103lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C1705388lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C0009015lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C1334309lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:10528196lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:10528196pubmed:issue9lld:pubmed
pubmed-article:10528196pubmed:dateCreated1999-11-19lld:pubmed
pubmed-article:10528196pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:abstractTextThe majority of the known Ly49 family members have been isolated from either C57BL/6 (B6) or BALB/c mice. Interestingly, the anti-Ly49 Ab reactivities observed in 129/J mice are different from those of B6 mice. Furthermore, immunoprecipitation of 129/J NK cell lysates with YE1/32 and YE1/48, Abs specific for the inhibitory Ly49A in B6, resulted in detection of the activation-associated DAP12 molecule. These results indicated a need for a more detailed study of this strain. Therefore, a cloning strategy was devised to isolate Ly49 cDNAs from 129/J mice. An immunoreceptor tyrosine-based inhibitory motif-containing, Ly49D-related clone was discovered that we have named Ly49O, and one immunoreceptor tyrosine-based inhibitory motif-lacking, Ly49A-related clone was discovered that we have named Ly49P. No anti-Ly49 mAb reacted with Ly49O, whereas the molecule encoded by the Ly49P cDNA was found to react with YE1/32 and YE1/48. Ly49P was found to associate with mouse DAP12, and Ab-mediated cross-linking of Ly49P resulted in mouse DAP12 phosphorylation and Ca2+ mobilization, indicating that Ly49P is a competent activation receptor. Ly49P, therefore, represents a novel member of the Ly49 activating receptor subfamily.lld:pubmed
pubmed-article:10528196pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:languageenglld:pubmed
pubmed-article:10528196pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528196pubmed:statusMEDLINElld:pubmed
pubmed-article:10528196pubmed:monthNovlld:pubmed
pubmed-article:10528196pubmed:issn0022-1767lld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:OrtaldoJ RJRlld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:GosselinPPlld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:MasonL HLHlld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:TaylorL SLSlld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:McVicarD WDWlld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:AndersonS KSKlld:pubmed
pubmed-article:10528196pubmed:authorpubmed-author:MakrigiannisA...lld:pubmed
pubmed-article:10528196pubmed:issnTypePrintlld:pubmed
pubmed-article:10528196pubmed:day1lld:pubmed
pubmed-article:10528196pubmed:volume163lld:pubmed
pubmed-article:10528196pubmed:ownerNLMlld:pubmed
pubmed-article:10528196pubmed:authorsCompleteYlld:pubmed
pubmed-article:10528196pubmed:pagination4931-8lld:pubmed
pubmed-article:10528196pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:meshHeadingpubmed-meshheading:10528196...lld:pubmed
pubmed-article:10528196pubmed:year1999lld:pubmed
pubmed-article:10528196pubmed:articleTitleCloning and characterization of a novel activating Ly49 closely related to Ly49A.lld:pubmed
pubmed-article:10528196pubmed:affiliationLaboratory of Experimental Immunology, Division of Basic Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702, USA.lld:pubmed
pubmed-article:10528196pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10528196pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:27423entrezgene:pubmedpubmed-article:10528196lld:entrezgene
entrez-gene:27424entrezgene:pubmedpubmed-article:10528196lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528196lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528196lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528196lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528196lld:pubmed